Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SFL-0821 in Adults With Facioscapulohumeral Muscular Dystrophy (FSHD)
NCT07798609Phase 2Recruiting
- Start
- Sep 2026
- Primary completion
- Mar 2028
- Countries
- 2
01
Overview
A Phase 2 trial of SFL-0821 in facioscapulohumeral muscular dystrophy (FSHD). Started Sep 2026; status: recruiting.
02
Drugs
SFL-0821
03
Conditions
facioscapulohumeral muscular dystrophy (FSHD)
Beyond the preview
Go deeper on NCT07798609.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07798609.